Nucleotide Sequences
QTLs in Region (mRatBN7.2)
RGD ID | Symbol | Name | LOD | P Value | Trait | Sub Trait | Chr | Start | Stop | Species | 1331796 | Thshl2 | Thyroid stimulating hormone level QTL 2 | 2.3 | blood thyroid-stimulating hormone amount (VT:0005119) | serum thyroid stimulating hormone level (CMO:0001248) | 5 | 97059760 | 147465714 | Rat | 10053720 | Scort26 | Serum corticosterone level QTL 26 | 2.06 | 0.0147 | blood corticosterone amount (VT:0005345) | plasma corticosterone level (CMO:0001173) | 5 | 124965598 | 166875058 | Rat | 1549845 | Scl44 | Serum cholesterol level QTL 44 | 6 | blood cholesterol amount (VT:0000180) | serum total cholesterol level (CMO:0000363) | 5 | 40128307 | 148607290 | Rat | 8552960 | Pigfal15 | Plasma insulin-like growth factor 1 level QTL 15 | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 5 | 111416838 | 156416838 | Rat | 631562 | Apr2 | Acute phase response QTL 2 | 3.7 | blood murinoglobulin 1 amount (VT:0010597) | plasma murinoglobulin 1 level (CMO:0001931) | 5 | 135927956 | 166875058 | Rat | 61444 | Strs2 | Sensitivity to stroke QTL 2 | 4.7 | cerebrum integrity trait (VT:0010549) | post-insult time to onset of cerebrovascular lesion (CMO:0002343) | 5 | 135929696 | 166875058 | Rat | 61452 | Ciaa5 | CIA Autoantibody QTL 5 | 3.5 | blood autoantibody amount (VT:0003725) | calculated serum anti-rat type 2 collagen autoantibody titer (CMO:0001281) | 5 | 94858972 | 143070159 | Rat | 70156 | Niddm30 | Non-insulin dependent diabetes mellitus QTL 30 | 3.98 | blood glucose amount (VT:0000188) | blood glucose level area under curve (AUC) (CMO:0000350) | 5 | 129132447 | 151006154 | Rat | 8552908 | Pigfal4 | Plasma insulin-like growth factor 1 level QTL 4 | 6.6 | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 5 | 128506074 | 166875058 | Rat | 1331803 | Rf32 | Renal function QTL 32 | 2.798 | kidney blood vessel physiology trait (VT:0100012) | absolute change in renal vascular resistance (CMO:0001900) | 5 | 129132428 | 143070159 | Rat | 61393 | Bp7 | Blood pressure QTL 7 | 4.5 | 0.0001 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 5 | 60293434 | 161481680 | Rat | 7794791 | Mcs33 | Mammary carcinoma susceptibility QTL 33 | 1.93 | mammary gland integrity trait (VT:0010552) | mammary tumor incidence/prevalence measurement (CMO:0000946) | 5 | 131345754 | 166875058 | Rat | 7207486 | Bss109 | Bone structure and strength QTL 109 | femur strength trait (VT:0010010) | femur total energy absorbed before break (CMO:0001677) | 5 | 106906205 | 151906205 | Rat | 7207481 | Bss106 | Bone structure and strength QTL 106 | 7.9 | femur strength trait (VT:0010010) | femur ultimate force (CMO:0001675) | 5 | 106906205 | 151906205 | Rat | 1302790 | Scl20 | Serum cholesterol level QTL 20 | 6.4 | 0.0001 | blood cholesterol amount (VT:0000180) | plasma total cholesterol level (CMO:0000585) | 5 | 82394392 | 166664054 | Rat | 1598861 | Cm64 | Cardiac mass QTL 64 | 2.9 | heart mass (VT:0007028) | heart weight to body weight ratio (CMO:0000074) | 5 | 127798274 | 166875058 | Rat | 1578766 | Tcas11 | Tongue tumor susceptibility QTL 11 | 4.12 | tongue integrity trait (VT:0010553) | number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) | 5 | 46711509 | 161317411 | Rat | 631505 | Bp103 | Blood pressure QTL 103 | 3.2 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 5 | 132717196 | 165560427 | Rat | 1549838 | Bss4 | Bone structure and strength QTL 4 | 9.2 | femur strength trait (VT:0010010) | femur midshaft polar moment of inertia (CMO:0001669) | 5 | 106906205 | 151906205 | Rat | 1641920 | Colcs1 | Colorectal carcinoma susceptibility QTL 1 | 2.99 | 0.0055 | intestine integrity trait (VT:0010554) | benign colorectal tumor surface area measurement (CMO:0001799) | 5 | 121846814 | 166846814 | Rat | 8694169 | Bw148 | Body weight QTL 148 | 5 | 0.001 | body mass (VT:0001259) | body weight gain (CMO:0000420) | 5 | 128506074 | 166875058 | Rat | 8657050 | Bw146 | Body weight QTL 146 | 19.84 | 0.001 | body mass (VT:0001259) | body weight gain (CMO:0000420) | 5 | 108938288 | 153938288 | Rat | 1581510 | Cm54 | Cardiac mass QTL 54 | 3.4 | 0.05 | heart left ventricle mass (VT:0007031) | heart left ventricle weight to body weight ratio (CMO:0000530) | 5 | 120740824 | 143608494 | Rat | 1576314 | Eutr1 | Estrogen induced uterine response QTL 1 | uterus integrity trait (VT:0010575) | pyometritis severity score (CMO:0002009) | 5 | 2138965 | 166875058 | Rat | 2317056 | Wbc3 | White blood cell count QTL 3 | 2.51 | 0.01 | leukocyte quantity (VT:0000217) | white blood cell count (CMO:0000027) | 5 | 105999803 | 150999803 | Rat | 634349 | Bp139 | Blood pressure QTL 139 | 0.001 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 5 | 128924607 | 166875058 | Rat | 724525 | Bp147 | Blood pressure QTL 147 | 4.3 | 0.0001 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 5 | 126424772 | 166875058 | Rat | 1598847 | Cm62 | Cardiac mass QTL 62 | 3.4 | heart mass (VT:0007028) | heart weight to body weight ratio (CMO:0000074) | 5 | 108845856 | 153845856 | Rat | 2293642 | Bss37 | Bone structure and strength QTL 37 | 4.64 | 0.0001 | femur strength trait (VT:0010010) | femur ultimate force (CMO:0001675) | 5 | 120740824 | 151018848 | Rat | 1578673 | Bmd13 | Bone mineral density QTL 13 | 4.9 | femur mineral mass (VT:0010011) | trabecular volumetric bone mineral density (CMO:0001729) | 5 | 103689353 | 148689353 | Rat | 738018 | Anxrr4 | Anxiety related response QTL 4 | 5.1 | exploratory behavior trait (VT:0010471) | percentage of entries into a discrete space in an experimental apparatus (CMO:0000961) | 5 | 130130159 | 166875058 | Rat | 7207488 | Bss110 | Bone structure and strength QTL 1 | 8.4 | femur strength trait (VT:0010010) | femur stiffness (CMO:0001674) | 5 | 106906205 | 151906205 | Rat | 8694441 | Bw169 | Body weight QTL 169 | 17.61 | 0.001 | retroperitoneal fat pad mass (VT:0010430) | retroperitoneal fat pad weight to body weight ratio (CMO:0000635) | 5 | 111416838 | 156416838 | Rat | 7207491 | Bss112 | Bone structure and strength QTL 112 | 7 | femur morphology trait (VT:0000559) | femur midshaft cortical cross-sectional area (CMO:0001663) | 5 | 106906205 | 151906205 | Rat | 8694389 | Bw160 | Body weight QTL 160 | 6.17 | 0.001 | body lean mass (VT:0010483) | lean tissue morphological measurement (CMO:0002184) | 5 | 111416838 | 156416838 | Rat | 61426 | Scl2 | Serum cholesterol level QTL 2 | 7.3 | 0.001 | blood cholesterol amount (VT:0000180) | serum total cholesterol level (CMO:0000363) | 5 | 59793399 | 143070159 | Rat | 1354598 | Srn6 | Serum renin concentration QTL 6 | 3.8 | blood renin amount (VT:0003349) | plasma renin activity level (CMO:0000116) | 5 | 69540295 | 151018848 | Rat | 8694198 | Abfw3 | Abdominal fat weight QTL 3 | 16.13 | 0.001 | visceral adipose mass (VT:0010063) | abdominal fat pad weight to body weight ratio (CMO:0000095) | 5 | 111416838 | 156416838 | Rat | 1298089 | Scl14 | Serum cholesterol level QTL 14 | 5.8 | 0.0004 | blood cholesterol amount (VT:0000180) | plasma total cholesterol level (CMO:0000585) | 5 | 108845856 | 153845856 | Rat | 1598819 | Bp292 | Blood pressure QTL 292 | 4.3 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 5 | 127798274 | 166875058 | Rat | 1358187 | Emca1 | Estrogen-induced mammary cancer QTL 1 | 4.4 | mammary gland integrity trait (VT:0010552) | post-insult time to mammary tumor formation (CMO:0000345) | 5 | 99216724 | 148607142 | Rat | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Additional Information